gandhi mathirai internal sagalaranangalukum kalimbu external in the management of madhumegaviranam

preclinical and open clinical trial of gandhi mathirai and sagala Ranangalukum kalimbu in the treatment of madhumega viranam - gandhi mathirai,sagala ranangalukum kalimbu,madhumega viranam

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/04/013023

Enrollment

Registered

2018-04-04

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- patient with diabetic ulcer with or without pain

Interventions

Intervention1: gandhi mathirai (internal) sagala ranangalukum kalimbu (external): gandhi mathirai is a herbo mineral preparation with dosage of 65mg(bid) with thirikadugu chooranam for 48 days sagala

Eligibility

Inclusion criteria

Inclusion criteria: patient include with diabetic ulcer ulcer with or without pain fibrogenous exudates edema inflammation and induration willing to give specimen of blood for investigation permit to take photograph

Exclusion criteria

Exclusion criteria: extensive and localised gangrene require amputation osteomyelitis deep ulceration with bone and joint involvement varicose ulcer tuberculuos ulcer any other systemic illness

Design outcomes

Primary

Measure	Time frame
bates- jensen wound assessment toolTimepoint: 1- 48 days	—

Secondary

Measure	Time frame
To assess the safety of trial drugTimepoint: 1-48 days	—

Countries

India

Contacts

Public Contactv mahalakshmi

National Institute of Siddha

njmuthu@hotmail.com9962006843

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026